吉三代(Epclusa) (吉三代)


$ 169

Item SKU:
  • US-9999
Quantity:

Name of Product: 吉三代(Epclusa) (吉三代)

Short Name of Product: 吉三代

description:

Gienoe, brand name: Gieno, generic name: Sofosbuvir + Velpatasvir, is a fixed-dose combination drug, including Sofosbuvir (HCVNS5B polymerase inhibitor, 400mg) and Velpatasvir (HCVNS5A inhibitor, 100mg), which is suitable for the treatment of adult patients with chronic hepatitis C infection of genotype 1, 2, 3, 4, 5 or 6. [Full name] Gienoe, Sofosbuvir Velpatasvir Tablets, Sofosbuvir Velpatasvir Tablets, Epclusa, MyHepAll, Velpanat, Velasof, Velpanex [Dosage] Once a day, one tablet each time, oral [Indications] 

● Gienoe is a fixed-dose combination drug, including Sofosbuvir (HCVNS5B polymerase inhibitor, 400mg), and Velpatasvir (HCVNS5A inhibitor, 100mg). 

● For the treatment of adult patients with chronic hepatitis C infection with genotype 1, 2, 3, 4, 5 or 6.

● Without cirrhosis or with compensated cirrhosis. 

● For decompensated cirrhosis, please use with ribavirin. Indications 

● Gienoe is a fixed-dose combination drug, including sofosbuvir (HCVNS5B polymerase inhibitor, 400mg), and velpatasvir (HCVNS5A inhibitor, 100mg). 

● For the treatment of adult patients with chronic hepatitis C infection with genotype 1, 2, 3, 4, 5 or 6. 

● Without cirrhosis or with compensated cirrhosis. 

● For decompensated cirrhosis, please use with ribavirin. Reference Usage Once a day, one tablet of Gienoe per tablet of sofosbuvir (400mg) + velpatasvir (100mg), take on an empty stomach or with food. Gienoe can be used alone or in combination with ribavirin to treat chronic hepatitis C (CHC). The following are the results of Gienoe: Gienoe for patients without cirrhosis or compensated cirrhosis: Gienoe alone with 12 weeks of 12 weeks. Gienoe for patients with decompensated cirrhosis: Gienoe + ribavirin, Gienoe for 12 weeks. Gienoe cannot be used in patients with severe renal impairment or end-stage renal disease. The recommended dose is Adverse Reactions 

● The most common adverse reactions (incidence ≥ 10%, all grades) after 12 weeks of treatment with Gienoe combined with ribavirin in patients with decompensated cirrhosis are: fatigue, anemia, nausea, headache, insomnia and diarrhea. Precautions 1. Pregnant women: The combination of Gienoe and ribavirin is contraindicated in pregnant women, and Gienoe is not suitable for use by the spouse of a pregnant woman. Please refer to the instructions for use of ribavirin and the risk of use during pregnancy for Gilead's third generation.


STAY IN TOUCH


生命之源(老挝)医药公司承销
Source of Life Pharmaceutical(Lao)Co.,Ltd

Company


公司营业执照号:768627145-000

网址: www.sourcelives.xyz

公司商务邮箱 [email protected]

客服邮箱 [email protected]

公司地址:万象市西科县,盛大商贸城A区二楼

公司电话:020-52221222

information


Contact Us